MR in Drug Research Study Group
Wednesday, 11 May 2011
18:15 - 20:15
Room 511A-C

18:15 MRDR Business Meeting Michael D. Cockman, Ph.D., Chair
18:30 Lecture: Employing MR Techniques for Objective Assessment of Liver Fibrosis Richard L. Ehman, M.D.
Mayo Clinic
Rochester, MN, USA
(Patricia E. Cole, M.D., Ph.D., Chair)
19:00 Lecture: MRI of Myocardial Fibrosis from a Cellular Level to Clinical Reality Andrew E. Arai, M.D.
Bethesda, MD, USA
(Béat M. Jucker, Ph.D., Chair)
19:30 Debate Topic: (Michael D. Cockman, Ph.D., Chair)
  What is Needed to Make Pre-Clinical MRI More Viable for Drug Development Studies?
Participants from Agilent Technologies, Bruker BioSpin and the pharmaceutical industry.
Case studies:
  • Application of DCE-MRI to tumor models
  • Application of ASL for brain studies
20:15 Adjourn